We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.7B
AUM Growth
+$473M
Cap. Flow
+$823M
Cap. Flow %
0.99%
Top 10 Hldgs %
14.9%
Holding
783
New
76
Increased
301
Reduced
323
Closed
81

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$431M
2
DAL icon
Delta Air Lines
DAL
+$318M
3
DE icon
Deere & Co
DE
+$282M
4
RHI icon
Robert Half
RHI
+$270M
5
CW icon
Curtiss-Wright
CW
+$265M

Sector Composition

Rank Sector Weight
1 Financials 21.07%
2 Technology 14.6%
3 Industrials 13.72%
4 Healthcare 11.92%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNC icon
126
Centene
CNC
$31.6B
$237M 0.29%
3,901,603
+2,373,280
+155% +$143M
BMY icon
127
Bristol-Myers Squibb
BMY
$128B
$236M 0.28%
3,866,114
-24,852
-0.6% -$1.45M
GNRC icon
128
Generac Holdings
GNRC
$11.6B
$235M 0.28%
1,853,666
-49,631
-3% -$7.12M
CHRW icon
129
C.H. Robinson
CHRW
$20.6B
$234M 0.28%
+2,299,150
New +$232M
SAIC icon
130
Saic
SAIC
$5.01B
$233M 0.28%
2,077,529
-225,338
-10% -$24.3M
FTDR icon
131
Frontdoor
FTDR
$5.1B
$230M 0.28%
5,980,271
+68,733
+1% +$3.5M
CNQ icon
132
Canadian Natural Resources
CNQ
$93.4B
$228M 0.28%
7,411,452
-1,505,414
-17% -$45.6M
NXPI icon
133
NXP Semiconductors
NXPI
$67.6B
$228M 0.28%
1,202,366
+379,629
+46% +$81M
SNY icon
134
Sanofi
SNY
$105B
$227M 0.27%
4,089,240
-1,307,291
-24% -$70.8M
RHI icon
135
Robert Half
RHI
$4.07B
$225M 0.27%
4,118,432
-4,435,844
-52% -$270M
KBR icon
136
KBR
KBR
$4.67B
$219M 0.26%
4,384,527
+1,142,111
+35% +$60.9M
CSCO icon
137
Cisco
CSCO
$452B
$216M 0.26%
3,497,487
-147,464
-4% -$9.08M
MOS icon
138
The Mosaic Company
MOS
$7.1B
$216M 0.26%
7,979,380
+2,368,094
+42% +$62.6M
EGP icon
139
EastGroup Properties
EGP
$11.3B
$212M 0.26%
1,202,462
+146,230
+14% +$25.4M
ICE icon
140
Intercontinental Exchange
ICE
$84.1B
$212M 0.26%
1,231,221
-245,047
-17% -$40.1M
RL icon
141
Ralph Lauren
RL
$22.6B
$212M 0.26%
958,321
-24,606
-3% -$6.1M
EWBC icon
142
East-West Bancorp
EWBC
$17.8B
$208M 0.25%
2,320,929
-62,355
-3% -$5.95M
HRB icon
143
H&R Block
HRB
$5.37B
$207M 0.25%
3,767,912
-732,640
-16% -$39.2M
ESS icon
144
Essex Property Trust
ESS
$18.7B
$206M 0.25%
671,191
+63,416
+10% +$18.5M
ROST icon
145
Ross Stores
ROST
$78.1B
$203M 0.25%
1,588,565
-35,730
-2% -$5M
NOMD icon
146
Nomad Foods
NOMD
$1.67B
$201M 0.24%
10,209,283
+1,019,957
+11% +$18.6M
TEL icon
147
TE Connectivity
TEL
$60.2B
$200M 0.24%
1,416,449
-588,202
-29% -$87.1M
VICI icon
148
VICI Properties
VICI
$29.5B
$199M 0.24%
6,086,385
-2,242,705
-27% -$69.1M
BALL icon
149
Ball Corp
BALL
$17.2B
$198M 0.24%
3,809,429
-1,281,615
-25% -$67.3M
BLDR icon
150
Builders FirstSource
BLDR
$7.82B
$198M 0.24%
1,588,173
-399,274
-20% -$58.1M

Similar funds

Boston Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Boston Partners held 783 positions worth $82.7B, up 0.58% from $82.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boston Partners's Q1 2025 filing shows 76 new, 301 increased, 323 reduced and 81 closed positions. Its largest new stake was Coca-Cola: 8,951,766 shares worth $642M. The largest sale was Amgen, an estimated $431M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

  • Boston Partners's largest Q1 2025 buy was Coca-Cola: 8,951,766 shares worth $642M.
  • Boston Partners added most to Allstate in Q1 2025, an estimated $416M increase.
  • Boston Partners's biggest Q1 2025 reduction was Amgen, cutting an estimated $431M.
  • Boston Partners fully exited Hologic in Q1 2025, selling an estimated $258M.
  • Boston Partners's ten largest holdings make up 15% of its $82.7B portfolio in Q1 2025.
  • Boston Partners opened 76 new positions and closed 81 in Q1 2025.
  • Boston Partners's portfolio value rose 0.58% quarter-over-quarter to $82.7B.

Based on Boston Partners's 13F filing for Q1 2025, filed 13 May 2025.